Clinical presentation, prognostic factors and treatment outcome of multiple myeloma (MM) in African American (AA) patients.

被引：0
|
作者：
Badros, Ashraf Z. [1 ]
Goloubeva, Olga [1 ]
Chumsri, Saranya [1 ]
Ruehle, Kathleen [1 ]
Ning, Yi [1 ]
Meekins, Joann [1 ]
Guedez, Liliana [1 ]
Rapoport, Aaron P. [1 ]
Meisenberg, Barry [1 ]
Akpek, Gorgon [1 ]
Yanovich, Saul [1 ]
Sausville, Edward [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5024
引用
收藏
页码：345B / 345B
页数：1
相关论文
共 50 条
  • [21] Differences in presentation and survival outcomes for African American patients with newly diagnosed multiple myeloma
    Joseph, Nisha
    Gupta, Vikas A.
    Hofmeister, Craig
    Gleason, Charise
    Heffner, Leonard T.
    Jonathan, Kafuman L.
    Boise, Lawrence H.
    Dhodapkar, Madhav D.
    Lonial, Sagar
    Nooka, Ajay K.
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Differences in Presentation and Survival Outcomes for African American Patients with Newly Diagnosed Multiple Myeloma
    Joseph, Nisha
    Gupta, Vikas A.
    Hofmeister, Craig C.
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Dhodapkar, Madhav V.
    Lonialand, Sagar
    Nooka, Ajay K.
    BLOOD, 2018, 132
  • [23] Thalidomide (Thal) in the treatment of advanced multiple myeloma (MM). A prospective study of 120 patients.
    Grosbois, B
    Bellissant, E
    Moreau, P
    Attal, M
    Zerbib, R
    BLOOD, 2001, 98 (11) : 163A - 163A
  • [24] Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: A clinical study of 110 patients in China
    Li, Yonghua
    Hou, Jian
    Wang, Dongxing
    Fu, Weijun
    Yuan, Zhengang
    Chen, Yubao
    Tao, Zhongfei
    LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2593 - 2600
  • [25] Prognostic value of microvessel density in multiple myeloma patients.
    Ahn, MJ
    Choi, JH
    Choi, IY
    Kim, ISK
    Lee, YY
    BLOOD, 2000, 96 (11) : 156A - 156A
  • [26] Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry.
    Toomey, Kathleen
    Gasparetto, Cristina
    Shah, Jatin J.
    Abonour, Rafat
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard R.
    Hardin, James W.
    Srinivasan, Shankar
    Larkins, Gail
    Ricafort, Rosanna J.
    Nagarwala, Yasir M.
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM).
    Ailawadhi, Sikander
    McCarthy, Philip L.
    Holstein, Sarah A.
    Larkins, Gail
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    Lonial, Sagar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Outcome and Prognostic Factors of 17p Deleted Multiple Myeloma Patients
    Kull, Miriam
    Teleanu, Veronica
    Hayde, Daniela
    Wildbihler, Katrin
    Harsdorf, Stephanie
    Bunjes, Donald
    Liebisch, Peter
    Langer, Christian
    BLOOD, 2014, 124 (21)
  • [29] Treatment of cardiovascular risk factors in African-American stroke patients.
    Schneck, MJ
    Leurgans, S
    Raman, R
    Gorelick, PB
    STROKE, 1999, 30 (01) : 253 - 253
  • [30] Outcome and prognostic factors of 17p deleted multiple myeloma patients
    Kull, M.
    Teleanu, V
    Schwarzwaeldr, P.
    Wildbihler, K.
    Hayde, D.
    Kolmus, S.
    Greiner, A.
    Liebisch, P.
    Langer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 18 - 18
12345